<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE nitf SYSTEM "http://www.nitf.org/IPTC/NITF/3.3/specification/dtd/nitf-3-3.dtd">
<nitf change.date="June 10, 2005" change.time="19:30" version="-//IPTC//DTD NITF 3.3//EN">
  <head>
    <title>Immunex Corp. reports earnings for Qtr to Dec 31</title>
    <meta content="14" name="publication_day_of_month"/>
    <meta content="2" name="publication_month"/>
    <meta content="1990" name="publication_year"/>
    <meta content="Wednesday" name="publication_day_of_week"/>
    <meta content="Financial Desk" name="dsk"/>
    <meta content="15" name="print_page_number"/>
    <meta content="D" name="print_section"/>
    <meta content="1" name="print_column"/>
    <meta content="Business" name="online_sections"/>
    <docdata>
      <doc-id id-string="326524"/>
      <doc.copyright holder="The New York Times" year="1990"/>
      <identified-content>
        <classifier class="indexing_service" type="descriptor">COMPANY REPORTS</classifier>
        <classifier class="online_producer" type="types_of_material">Statistics</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/News/Business</classifier>
        <classifier class="online_producer" type="general_descriptor">Company Reports</classifier>
        <classifier class="online_producer" type="general_descriptor">Corporations</classifier>
      </identified-content>
    </docdata>
    <pubdata date.publication="19900214T000000" ex-ref="http://query.nytimes.com/gst/fullpage.html?res=9E05E7D61E3EF937A25751C0A966958260" item-length="101" name="The New York Times" unit-of-measure="word"/>
  </head>
  <body>
    <body.head>
      <hedline>
        <hl1>Immunex Corp. reports earnings for Qtr to Dec 31</hl1>
      </hedline>
    </body.head>
    <body.content>
      <block class="lead_paragraph">
        <p>LEAD:</p>
        <p>*3*** COMPANY REPORTS **</p>
        <p>*3* Immunex Corp. (OTC)</p>
        <p>Qtr to Dec 31</p>
        <p>1989</p>
        <p>1988</p>
        <p>Revenue</p>
        <p>7,400,000</p>
        <p>5,600,000</p>
        <p>Net loss</p>
        <p>b4,800,000</p>
        <p>97,000</p>
        <p>Yr rev</p>
        <p>28,166,000</p>
        <p>22,234,000</p>
        <p>Net loss</p>
        <p>c14,245,000</p>
        <p>d657,000</p>
        <p>b-Included $2.4 million in accrued payments related to the acquisition of rights to new products.</p>
      </block>
      <block class="full_text">
        <p>LEAD:</p>
        <p>*3*** COMPANY REPORTS **</p>
        <p>*3* Immunex Corp. (OTC)</p>
        <p>Qtr to Dec 31</p>
        <p>1989</p>
        <p>1988</p>
        <p>Revenue</p>
        <p>7,400,000</p>
        <p>5,600,000</p>
        <p>Net loss</p>
        <p>b4,800,000</p>
        <p>97,000</p>
        <p>Yr rev</p>
        <p>28,166,000</p>
        <p>22,234,000</p>
        <p>Net loss</p>
        <p>c14,245,000</p>
        <p>d657,000</p>
        <p>b-Included $2.4 million in accrued payments related to the acquisition of rights to new products.</p>
        <p>*3*** COMPANY REPORTS **</p>
        <p>*3* Immunex Corp. (OTC)</p>
        <p>Qtr to Dec 31</p>
        <p>1989</p>
        <p>1988</p>
        <p>Revenue</p>
        <p>7,400,000</p>
        <p>5,600,000</p>
        <p>Net loss</p>
        <p>b4,800,000</p>
        <p>97,000</p>
        <p>Yr rev</p>
        <p>28,166,000</p>
        <p>22,234,000</p>
        <p>Net loss</p>
        <p>c14,245,000</p>
        <p>d657,000</p>
        <p>b-Included $2.4 million in accrued payments related to the acquisition of rights to new products.</p>
        <p>c-Included one-time charge of $7.3 million for the acquisition of marketing and manufacturing rights to products Immunex intends to market.</p>
        <p>d-Net income</p>
        <p>There were no share earnings in the 1988 year after preferred dividend requirements.</p>
      </block>
    </body.content>
  </body>
</nitf>
